Alicia Zellmer, MD, and Joy Liu, MD, are resident physicians in internal medicine and members of the ABC News Medical Unit.
REFERENCES: (1) Advancing regenerative surgery in orthopaedic sports medicine: the critical role of the surgeon (2) The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects (3) Platelet-Rich Fibrin and Its Emerging Therapeutic Benefits for Musculoskeletal Injury Treatment (4) Platelet-Rich Fibrin Scaffolds for Cartilage and Tendon Regenerative Medicine: From Bench to Bedside (5) From Platelet-Rich Plasma to Advanced Platelet-Rich Fibrin: Biological Achievements and Clinical Advances in Modern Surgery (6) Leucocyte and Plateletrich Fibrin: a carrier of autologous multipotent cells for regenerative medicine (7) Cytokine and Growth Factor Delivery from Implanted Platelet-Rich Fibrin Enhances Rabbit Achilles Tendon Healing (8) Cartilage Defect Treatments: A Systematic Review and Meta-Analyses (9) Regenerative approaches for the treatment of early OA (10) Stem Cells in Osteochondral Tissue Engineering (11) Circulating stem cells (12) Peripheral blood and bone marrow hematopoietic stem cells: are they the same
Fistula length of 4 mm was surgically created as a junction between the duodenum (1 cm aboral from pylorus) and colon (2 cm aboral from ileocecal valve)
They are susceptible to degradation pathways that small molecules simply do not face, including deamidation, oxidation, aggregation, and hydrolysis
A 2024 review in Cartilage identified AOD-9604 among key peptides recognized for benefits to bone and joint health, noting its capacity for chondrogenic induction and cartilage regeneration in osteoarthritis models
